SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade

Journal:

Nature

Published:

2025-10-22

DOI:

10.1038/s41586-025-09655-y

Affiliations:

28

Authors:

139

Go to article

Institutions	Authors	Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)	112.000000 112.000000 112.000000 112.000000 112.000000 112.000000 112.000000 112.000000 112.000000 112.000000 112.000000 112.000000	0.81
University of Florida Health (UF Health), United States of America (USA)	11.000000 11.000000	0.08
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	4.000000	0.03
University of Florida (UF), United States of America (USA)	2.000000	0.01
Baylor College of Medicine (BCM), United States of America (USA)	1.000000	0.01
Stanford University, United States of America (USA)	1.000000	0.01
Scripps Health, United States of America (USA)	1.000000	0.01
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.01
Ascension, United States of America (USA)	1.000000	0.01
The University of Texas Health Science Center at San Antonio (UT Health San Antonio), United States of America (USA)	1.000000	0.01
Oracle Corporation, United States of America (USA)	1.000000	0.01
Medical College of Wisconsin (MCW), United States of America (USA)	1.000000	0.01
Sarah Cannon Research Institute (SCRI), United States of America (USA)	1.000000	0.01
Peter MacCallum Cancer Centre (Peter Mac), Australia	0.500000	0.00
Monash University, Australia	0.500000	0.00

Interested in Oncology and Carcinogenesis?